Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

455
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
455
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

326
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
326
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

559
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
559
Pyruvate Oxidation01:15

Pyruvate Oxidation

168.2K
After glycolysis, the charged pyruvate molecules enter the mitochondria via active transport and undergo three enzymatic reactions. These reactions ensure that pyruvate can enter the next metabolic pathway so that energy stored in the pyruvate molecules can be harnessed by the cells.
First, the enzyme pyruvate dehydrogenase removes the carboxyl group from pyruvate and releases it as carbon dioxide. The stripped molecule is then oxidized and releases electrons, which are then picked up by NAD+...
168.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydrogen-Deuterium Back-Exchange for High-Resolution Mass-Spectrometry-Based Metabolite Characterization.

Analytical chemistry·2026
Same author

Manipulation of Gas-Phase Charge Inversion Ion/Ion Reaction Kinetics for Improved Phospholipid Identification in Imaging Mass Spectrometry.

Journal of the American Society for Mass Spectrometry·2026
Same author

Rocuronium Dose and First-Attempt Intubation Success in the Critically Ill: Secondary Analysis of Two Multicenter Trials.

American journal of respiratory and critical care medicine·2026
Same author

Ozonolysis of Strontium-Adducted Phosphatidylcholines in the Gas Phase: Expanding the Isomeric Coverage of Ozone-Induced Dissociation.

Journal of the American Society for Mass Spectrometry·2026
Same author

Video versus direct laryngoscopy for tracheal intubation in trauma: A secondary analysis of the DEVICE trial.

The journal of trauma and acute care surgery·2026
Same author

Best practices for critically ill patients boarding in the emergency department: A Delphi study.

The American journal of emergency medicine·2026

Related Experiment Video

Updated: Jan 12, 2026

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

8.0K

Pyruvate Dehydrogenase Complex Stimulation With Dichloroacetate May Improve Septic Cardiac Dysfunction.

Lane M Smith1, Yu Tin Lin2, Chelsey S Mertens1

  • 1Department of Internal Medicine, Division of Critical Care Medicine, Wake Forest School of Medicine, Charlotte, North Carolina.

Shock (Augusta, Ga.)
|October 31, 2025
PubMed
Summary
This summary is machine-generated.

Dichloroacetate (DCA) rebalances pyruvate dehydrogenase (PDH) activity, improving cardiac function in a mouse model of sepsis. This study investigates DCA

Keywords:
Cardiomyopathyinfectioninflammationmetabolismshock

More Related Videos

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.8K
Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts
08:51

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts

Published on: May 12, 2019

7.1K

Related Experiment Videos

Last Updated: Jan 12, 2026

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

8.0K
Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.8K
Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts
08:51

Intra-cardiac Side-Firing Light Catheter for Monitoring Cellular Metabolism using Transmural Absorbance Spectroscopy of Perfused Mammalian Hearts

Published on: May 12, 2019

7.1K

Area of Science:

  • Cardiology
  • Metabolism
  • Sepsis Research

Background:

  • Sepsis-induced cardiomyopathy increases mortality.
  • Molecular mechanisms of septic cardiomyopathy remain unclear.
  • Dichloroacetate (DCA) targets pyruvate dehydrogenase kinase (PDK) to activate pyruvate dehydrogenase (PDH).

Purpose of the Study:

  • To investigate the role of DCA in septic cardiac dysfunction.
  • To explore DCA's effects on cardiac performance and metabolism in a murine sepsis model.

Main Methods:

  • Cecal ligation and puncture (CLP) induced sepsis in mice.
  • DCA administered to assess PDH activation's impact on cardiac function and metabolism.
  • Matrix-assisted laser desorption/ionization imaging mass spectrometry analyzed metabolic alterations.

Main Results:

  • CLP increased PDH inactivation (phosphorylation); DCA reversed this.
  • DCA improved cardiac preload and stroke volume at 12 hours post-CLP.
  • DCA enhanced cardiac contractility at 30 hours post-CLP and altered metabolic intermediates, including itaconate.

Conclusions:

  • Sepsis reduces cardiac PDH activity.
  • DCA administration improved cardiac performance in a murine sepsis model.
  • Further research is needed to confirm DCA's therapeutic potential for septic cardiomyopathy.